MEET OUR TEAM

Please meet the people behind our company, led by Tom Wiggans, with additional industry veterans from Connetics, Peplin, Stiefel and Gilead.

TECHNOLOGY SPOTLIGHT

Cimzia®, our lead product candidate, is a PEGylated, humanized antigen-binding mAb fragment TNF inhibitor in development for the treatment of moderate-to-severe plaque psoriasis.

Dermira is a biopharmaceutical company dedicated to identifying, developing and commercializing innovative, differentiated therapies to improve the lives of patients with dermatologic diseases.